CMS proposal would be positive for Guardant Health, says Craig-Hallum

After the Centers for Medicare and Medicaid Services yesterday came out with its 2025 Medicare Hospital outpatient reimbursement proposal and Physician Fee Schedule, Craig-Hallum noted that an update to the “Complete CRC Screening” program was included in the proposed rule. The update would be positive for Guardant Health (GH) as it would remove one potential barrier to physicians ordering Guardant Shield and other FDA-approved blood-based tests, the analyst tells investors. While the update may be perceived as negative for Exact Sciences (EXAS), the firm sees it differently and is “not especially concerned,” added the analyst, who has Buy ratings on both Guardant and Exact.